OTC Markets OTCQB USD

Northwest Biotherapeutics, Inc. (NWBO)

Compare
0.4320 +0.0120 (+2.86%)
At close: June 14 at 3:59 PM EDT

Valuation Measures

Annual
Monthly
Currency in USD
Download
Current3/31/202412/31/20239/30/20236/30/20233/31/202312/31/2022
Market Cap 523.10M 617.59M 808.85M 1.02B 633.43M 676.94M --
Enterprise Value 569.70M 661.03M 840.19M 1.05B 658.61M 696.23M --
Trailing P/E 81.98 -- -- -- -- -- --
Forward P/E -- -- -- -- -- -- --
PEG Ratio (5yr expected) -- -- -- -- -- -- --
Price/Sales 371.05 300.65 368.04 517.07 274.73 377.25 --
Price/Book -- -- -- -- -- -- --
Enterprise Value/Revenue 426.42 342.15 403.16 556.89 304.91 413.68 --
Enterprise Value/EBITDA -- -- -48.69 -63.89 -51.76 -75.49 13.27
12/31/2022 - 12/14/2001

Upgrade to begin using 40 years of earnings data and get so much more.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Upgrade

Financial Highlights

Fiscal Year

Fiscal Year Ends 12/31/2023
Most Recent Quarter (mrq) 3/31/2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm) -5,543.66%

Management Effectiveness

Return on Assets (ttm) -118.59%
Return on Equity (ttm) --

Income Statement

Revenue (ttm) 1.34M
Revenue Per Share (ttm) 0.00
Quarterly Revenue Growth (yoy) -67.70%
Gross Profit (ttm) --
EBITDA -56.67M
Net Income Avi to Common (ttm) -72.21M
Diluted EPS (ttm) -0.0700
Quarterly Earnings Growth (yoy) --

Balance Sheet

Total Cash (mrq) 2.48M
Total Cash Per Share (mrq) 0
Total Debt (mrq) 49.08M
Total Debt/Equity (mrq) --
Current Ratio (mrq) 0.08
Book Value Per Share (mrq) -0.06

Cash Flow Statement

Operating Cash Flow (ttm) -54.8M
Levered Free Cash Flow (ttm) -38.43M

Trading Information

Stock Price History

Beta (5Y Monthly) -0.64
52 Week Range 3 -27.12%
S&P 500 52-Week Change 3 23.76%
52 Week High 3 1.0900
52 Week Low 3 0.4000
50-Day Moving Average 3 0.4750
200-Day Moving Average 3 0.6332

Share Statistics

Avg Vol (3 month) 3 1.66M
Avg Vol (10 day) 3 1.48M
Shares Outstanding 5 1.21B
Implied Shares Outstanding 6 1.25B
Float 8 1.1B
% Held by Insiders 1 9.16%
% Held by Institutions 1 0.05%
Shares Short (11/30/2016) 4 14.14M
Short Ratio (11/30/2016) 4 13.54
Short % of Float (11/30/2016) 4 15.09%
Short % of Shares Outstanding (11/30/2016) 4 11.34%
Shares Short (prior month 10/31/2016) 4 13.83M

Dividends & Splits

Forward Annual Dividend Rate 4 --
Forward Annual Dividend Yield 4 --
Trailing Annual Dividend Rate 3 0.00
Trailing Annual Dividend Yield 3 0.00%
5 Year Average Dividend Yield 4 --
Payout Ratio 4 0.00%
Dividend Date 3 --
Ex-Dividend Date 4 --
Last Split Factor 2 1:16
Last Split Date 3 9/26/2012

Footnotes

  • 1 Data provided by Refinitiv.
  • 2 Data provided by EDGAR Online.
  • 3 Data derived from multiple sources or calculated by Yahoo Finance.
  • 4 Data provided by Morningstar, Inc.
  • 5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
  • 6 Implied Shares Outstanding of common equity, assuming the conversion of all convertible subsidiary equity into common.
  • 7 EBITDA is calculated by S&P Global Market Intelligence using methodology that may differ from that used by a company in its reporting.
  • 8 A company's float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which may not be publicly traded.

Abbreviation Guide

  • mrq = Most Recent Quarter
  • ttm = Trailing Twelve Months
  • yoy = Year Over Year
  • lfy = Last Fiscal Year
  • fye = Fiscal Year Ending

Related Tickers